The neural adhesion molecule CD56 is normally expressed on natural killer cells and subsets of T cells and is commonly found in hematolymphoid neoplasms. Expression of CD56 is very rare in B-cell lymphoma and most reported CD56-positive cases were diffuse large B-cell lymphomas. Cases of CD56-positive mantle cell lymphoma (MCL) have not previously been described in the literature. We present a case of CD56-positive MCL. To the best of our knowledge, this is the first case report of MCL expressing CD56.
SwerdlowS.H., HarrisN.L., JaffeE.S., PileriS.A., SteinH., ThieleJ., VardimanJ.W.: WHO classification of tumours of haematopoietic and lymphoid tissues.International Agency for Research on Cancer, Lyon, 2008.
MoriceW.G., HodnefieldJ.M., KurtinP.J., HansonC.A.: An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.Am J Clin Pathol, 122: 122–127, 2004.
GriffinJ.D., HercendT., BeveridgeR., SchlossmanS.F.: Characterization of an antigen expressed by human natural killer cells.J Immunol, 130: 2947–2951, 1983.
SekitaT., TamaruJ.I., IsobeK., HarigayaK., MasuokaS., KatayamaT., KobayashiM., MikataA.: Diffuse large B cell lymphoma expressing the natural killer cell marker CD56.Pathol Int, 49: 752–758, 1999.
15.
ParrensM., Belaud-RotureauM.A., FitoussiO., CarerreN., BouabdallahK., MaritG., DubusP., de MascarelA., MerlioJ.P.: Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.Histopathol, 110: 353–362, 2006.
ReynaudD., LefortN., ManieE., CoulombelL., LevyY.: In vitro identification of human pro-B cells that give rise to macrophages, natural killer cells, and T cells.Blood, 101: 4313–4321, 2003.
18.
GomyoH., KajimotoK., MiyataY., MaedaA., MizunoI., YamamotoK., ObayashiC., HaniokaK., MurayamaT.: CD56-positive diffuse large B-cell lymphoma: possible association with extranodal involvement and BCL-6 expression.Hematology, 15: 157–161, 2010.
19.
Sanchez-BeatoM., CamachoF.I., Martinez-MonteroJ.C., SaezA.I., VilluendasR., Sanchez-VerdeL., GarciaJ.F., PirisM.A.: Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.Blood, 94: 765–772, 1999.
20.
EhingerM., LinderothJ., ChristenssonB., SanderB., Cavallin-StahlE.: A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus.Am J Clin Pathol, 129: 630–638, 2008.
21.
BaiM., TsanouE., AgnantisN.J., ChaidosA., DimouD., SkyrlasA., DimouS., VlychouM., GalaniV., KanavarosP.: Expression of cyclin D3 and cyclin E and identification of distinct clusters of proliferation and apoptosis in diffuse large B-cell lymphomas.Histol Histopathol, 18: 449–457, 2003.
22.
HaradaS., SuzukiR., UehiraK., YatabeY., KagamiY., OguraM., SuzukiH., OyamaA., KoderaY., UedaR., MorishimaY., NakamuraS., SetoM.: Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes.Leukemia, 13: 1441–1447, 1999.
23.
OttM.M., BartkovaJ., BartekJ., DurrA., FischerL., OttG., Muller-HermelinkH.K., KreipeH.: Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity.Blood, 90: 3154–3159, 1997.
24.
ZukerbergL.R., YangW.I., ArnoldA., HarrisN.L.: Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry.Am J Clin Pathol, 103: 756–760, 1995.
25.
XuY., McKennaR.W., KroftS.H.: Assessment of CD10 in the diagnosis of small B-cell lymphomas: a multiparameter flow cytometric study.Am J Clin Pathol, 117: 291–300, 2002.
